Outlook Therapeutics
OTLK
£1.08
Share price
8.53%
Change (1 day)
-85.44%
Change (1 year)
Categories
EPS for Outlook Therapeutics (OTLK)
EPS in 2023 (TTM): -£0.21
According to Outlook Therapeutics 's latest financial reports the company's current EPS (TTM) is -£0.19. In 2022 the company made an earnings per share (EPS) of -£0.24 an increase over its 2021 EPS that were of -£0.25.
EPS history for Outlook Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -£0.21 | -13.33% |
| 2022 | -£0.24 | -3.13% |
| 2021 | -£0.25 | -45.58% |
| 2020 | -£0.45 | -72.76% |
| 2019 | -£1.67 | -69.86% |
| 2018 | -£5.53 | -42.98% |
| 2017 | -£9.70 | -45.12% |
| 2016 | -£17.67 | -32.39% |
| 2015 | -£26.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -£1.44 | 644.00% | Jersey |
 | -£5.55 | 2,776.00% | 🇺🇸 USA |
 | -£1.59 | 724.00% | 🇺🇸 USA |
 | -£4.79 | 2,380.00% | 🇬🇧 UK |